Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selectionFilippo Montemurro, Gabriela Rondón, Mark Munsell, et al.Human Pathology|March 3, 2004
Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemiaCarlos E Bueso-Ramos, Frederico C Rocha, Shishir Shishodia, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapyYee Chung Cheng, Gabriela Rondón, Ying Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancerFrancisco J Esteva, Aysegul A Sahin, George Z Rassidakis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trialEva Thomas, Frankie A Holmes, Terry L Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerFrancisco J Esteva, Vicente Valero, Daniel Booser, et al.Blood|October 24, 2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphomaApostolia M Tsimberidou, Peter McLaughlin, Anas Younes, et al.Cancer|March 26, 2004
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of responseRadhika Rajan, Anna Poniecka, Terry L Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphomaJohn F Seymour, Barbara Pro, Lillian M Fuller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancerLajos Pusztai, Jim Hou Zhen, Banu Arun, et al.Pageof 5